Logo image of CRAYN.OL

CRAYON GROUP HOLDING AS (CRAYN.OL) Stock Fundamental Analysis

OSL:CRAYN - Euronext Oslo - NO0010808892 - Common Stock - Currency: NOK

144  -0.5 (-0.35%)

Fundamental Rating

5

We assign a fundamental rating of 5 out of 10 to CRAYN. CRAYN was compared to 101 industry peers in the Software industry. CRAYN scores excellent on profitability, but there are concerns on its financial health. CRAYN is valued quite cheap, while showing a decent growth score. This is a good combination!


Dividend Valuation Growth Profitability Health

7

1. Profitability

1.1 Basic Checks

In the past year CRAYN was profitable.
CRAYN had a positive operating cash flow in the past year.
CRAYN had positive earnings in 4 of the past 5 years.
Each year in the past 5 years CRAYN had a positive operating cash flow.
CRAYN.OL Yearly Net Income VS EBIT VS OCF VS FCFCRAYN.OL Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M 1B

1.2 Ratios

CRAYN has a Return On Assets of 1.53%. This is comparable to the rest of the industry: CRAYN outperforms 56.44% of its industry peers.
CRAYN has a better Return On Equity (10.80%) than 67.33% of its industry peers.
With an excellent Return On Invested Capital value of 11.88%, CRAYN belongs to the best of the industry, outperforming 84.16% of the companies in the same industry.
The Average Return On Invested Capital over the past 3 years for CRAYN is below the industry average of 10.93%.
The last Return On Invested Capital (11.88%) for CRAYN is above the 3 year average (8.15%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 1.53%
ROE 10.8%
ROIC 11.88%
ROA(3y)0.27%
ROA(5y)0.94%
ROE(3y)1.7%
ROE(5y)5.34%
ROIC(3y)8.15%
ROIC(5y)8.32%
CRAYN.OL Yearly ROA, ROE, ROICCRAYN.OL Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 -5 10 -10 -15

1.3 Margins

CRAYN has a Profit Margin (4.12%) which is in line with its industry peers.
In the last couple of years the Profit Margin of CRAYN has declined.
With a decent Operating Margin value of 11.00%, CRAYN is doing good in the industry, outperforming 66.34% of the companies in the same industry.
In the last couple of years the Operating Margin of CRAYN has grown nicely.
CRAYN's Gross Margin of 89.27% is amongst the best of the industry. CRAYN outperforms 88.12% of its industry peers.
In the last couple of years the Gross Margin of CRAYN has grown nicely.
Industry RankSector Rank
OM 11%
PM (TTM) 4.12%
GM 89.27%
OM growth 3Y-1%
OM growth 5Y62.81%
PM growth 3Y-16.95%
PM growth 5YN/A
GM growth 3Y1.37%
GM growth 5Y46.49%
CRAYN.OL Yearly Profit, Operating, Gross MarginsCRAYN.OL Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 40 60 80

3

2. Health

2.1 Basic Checks

CRAYN has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
CRAYN has more shares outstanding than it did 1 year ago.
The number of shares outstanding for CRAYN has been increased compared to 5 years ago.
Compared to 1 year ago, CRAYN has an improved debt to assets ratio.
CRAYN.OL Yearly Shares OutstandingCRAYN.OL Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M
CRAYN.OL Yearly Total Debt VS Total AssetsCRAYN.OL Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B

2.2 Solvency

Based on the Altman-Z score of 1.02, we must say that CRAYN is in the distress zone and has some risk of bankruptcy.
CRAYN's Altman-Z score of 1.02 is on the low side compared to the rest of the industry. CRAYN is outperformed by 71.29% of its industry peers.
The Debt to FCF ratio of CRAYN is 1.61, which is an excellent value as it means it would take CRAYN, only 1.61 years of fcf income to pay off all of its debts.
With a decent Debt to FCF ratio value of 1.61, CRAYN is doing good in the industry, outperforming 75.25% of the companies in the same industry.
CRAYN has a Debt/Equity ratio of 0.58. This is a neutral value indicating CRAYN is somewhat dependend on debt financing.
The Debt to Equity ratio of CRAYN (0.58) is worse than 63.37% of its industry peers.
Even though the debt/equity ratio score it not favorable for CRAYN, it has very limited outstanding debt, so we won't put too much weight on the DE evaluation.
Industry RankSector Rank
Debt/Equity 0.58
Debt/FCF 1.61
Altman-Z 1.02
ROIC/WACC1.23
WACC9.67%
CRAYN.OL Yearly LT Debt VS Equity VS FCFCRAYN.OL Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B 2B 3B

2.3 Liquidity

A Current Ratio of 0.98 indicates that CRAYN may have some problems paying its short term obligations.
Looking at the Current ratio, with a value of 0.98, CRAYN is doing worse than 68.32% of the companies in the same industry.
CRAYN has a Quick Ratio of 0.98. This is a bad value and indicates that CRAYN is not financially healthy enough and could expect problems in meeting its short term obligations.
CRAYN's Quick ratio of 0.98 is on the low side compared to the rest of the industry. CRAYN is outperformed by 67.33% of its industry peers.
Industry RankSector Rank
Current Ratio 0.98
Quick Ratio 0.98
CRAYN.OL Yearly Current Assets VS Current LiabilitesCRAYN.OL Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B

5

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 44.17% over the past year.
CRAYN shows quite a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 8.95% yearly.
CRAYN shows a small growth in Revenue. In the last year, the Revenue has grown by 7.67%.
The Revenue for CRAYN have been decreasing by -12.43% on average. This is quite bad
EPS 1Y (TTM)44.17%
EPS 3Y8.95%
EPS 5YN/A
EPS Q2Q%38.61%
Revenue 1Y (TTM)7.67%
Revenue growth 3Y25.66%
Revenue growth 5Y-12.43%
Sales Q2Q%6.61%

3.2 Future

The Earnings Per Share is expected to grow by 48.55% on average over the next years. This is a very strong growth
The Revenue is expected to decrease by -1.25% on average over the next years.
EPS Next Y108.12%
EPS Next 2Y65.95%
EPS Next 3Y48.55%
EPS Next 5YN/A
Revenue Next Year13.29%
Revenue Next 2Y13.92%
Revenue Next 3Y13.37%
Revenue Next 5Y-1.25%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
CRAYN.OL Yearly Revenue VS EstimatesCRAYN.OL Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 5B 10B 15B 20B 25B
CRAYN.OL Yearly EPS VS EstimatesCRAYN.OL Yearly EPS VS EstimatesYearly EPS VS Estimates 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 2 4 6 8 10

7

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 35.29, which means the current valuation is very expensive for CRAYN.
Based on the Price/Earnings ratio, CRAYN is valued a bit cheaper than the industry average as 74.26% of the companies are valued more expensively.
When comparing the Price/Earnings ratio of CRAYN to the average of the S&P500 Index (27.30), we can say CRAYN is valued slightly more expensively.
CRAYN is valuated correctly with a Price/Forward Earnings ratio of 13.49.
CRAYN's Price/Forward Earnings ratio is rather cheap when compared to the industry. CRAYN is cheaper than 86.14% of the companies in the same industry.
CRAYN is valuated rather cheaply when we compare the Price/Forward Earnings ratio to 21.76, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 35.29
Fwd PE 13.49
CRAYN.OL Price Earnings VS Forward Price EarningsCRAYN.OL Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of CRAYN indicates a somewhat cheap valuation: CRAYN is cheaper than 72.28% of the companies listed in the same industry.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of CRAYN indicates a rather cheap valuation: CRAYN is cheaper than 90.10% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 11.23
EV/EBITDA 11.79
CRAYN.OL Per share dataCRAYN.OL EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 20 40 60

4.3 Compensation for Growth

CRAYN's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
CRAYN has a very decent profitability rating, which may justify a higher PE ratio.
A more expensive valuation may be justified as CRAYN's earnings are expected to grow with 48.55% in the coming years.
PEG (NY)0.33
PEG (5Y)N/A
EPS Next 2Y65.95%
EPS Next 3Y48.55%

0

5. Dividend

5.1 Amount

CRAYN does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

CRAYON GROUP HOLDING AS

OSL:CRAYN (7/2/2025, 7:00:00 PM)

144

-0.5 (-0.35%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)05-21 2025-05-21/bmo
Earnings (Next)08-27 2025-08-27
Inst Owners59.97%
Inst Owner ChangeN/A
Ins Owners1.32%
Ins Owner ChangeN/A
Market Cap12.90B
Analysts76
Price Target144.46 (0.32%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-49.25%
Min EPS beat(2)-60.61%
Max EPS beat(2)-37.9%
EPS beat(4)0
Avg EPS beat(4)-35.83%
Min EPS beat(4)-60.61%
Max EPS beat(4)-13.94%
EPS beat(8)2
Avg EPS beat(8)-24.98%
EPS beat(12)2
Avg EPS beat(12)-66.98%
EPS beat(16)5
Avg EPS beat(16)-94.94%
Revenue beat(2)0
Avg Revenue beat(2)-8.54%
Min Revenue beat(2)-9.83%
Max Revenue beat(2)-7.25%
Revenue beat(4)0
Avg Revenue beat(4)-7.68%
Min Revenue beat(4)-9.83%
Max Revenue beat(4)-4.06%
Revenue beat(8)3
Avg Revenue beat(8)-3.98%
Revenue beat(12)5
Avg Revenue beat(12)-13.42%
Revenue beat(16)5
Avg Revenue beat(16)-31.36%
PT rev (1m)0.55%
PT rev (3m)0.55%
EPS NQ rev (1m)-2.8%
EPS NQ rev (3m)-1.78%
EPS NY rev (1m)0%
EPS NY rev (3m)-0.6%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-1.93%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-0.11%
Valuation
Industry RankSector Rank
PE 35.29
Fwd PE 13.49
P/S 1.81
P/FCF 11.23
P/OCF 9.75
P/B 4.76
P/tB N/A
EV/EBITDA 11.79
EPS(TTM)4.08
EY2.83%
EPS(NY)10.68
Fwd EY7.41%
FCF(TTM)12.83
FCFY8.91%
OCF(TTM)14.77
OCFY10.26%
SpS79.49
BVpS30.28
TBVpS-11.43
PEG (NY)0.33
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 1.53%
ROE 10.8%
ROCE 17.55%
ROIC 11.88%
ROICexc 17.65%
ROICexgc N/A
OM 11%
PM (TTM) 4.12%
GM 89.27%
FCFM 16.14%
ROA(3y)0.27%
ROA(5y)0.94%
ROE(3y)1.7%
ROE(5y)5.34%
ROIC(3y)8.15%
ROIC(5y)8.32%
ROICexc(3y)11.91%
ROICexc(5y)28.33%
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)12.05%
ROCE(5y)12.29%
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3Y22.85%
ROICexc growth 5Y8.87%
OM growth 3Y-1%
OM growth 5Y62.81%
PM growth 3Y-16.95%
PM growth 5YN/A
GM growth 3Y1.37%
GM growth 5Y46.49%
F-Score6
Asset Turnover0.37
Health
Industry RankSector Rank
Debt/Equity 0.58
Debt/FCF 1.61
Debt/EBITDA 1.4
Cap/Depr 50.58%
Cap/Sales 2.44%
Interest Coverage 250
Cash Conversion 117.39%
Profit Quality 392.15%
Current Ratio 0.98
Quick Ratio 0.98
Altman-Z 1.02
F-Score6
WACC9.67%
ROIC/WACC1.23
Cap/Depr(3y)45.9%
Cap/Depr(5y)48.63%
Cap/Sales(3y)2.42%
Cap/Sales(5y)2%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)44.17%
EPS 3Y8.95%
EPS 5YN/A
EPS Q2Q%38.61%
EPS Next Y108.12%
EPS Next 2Y65.95%
EPS Next 3Y48.55%
EPS Next 5YN/A
Revenue 1Y (TTM)7.67%
Revenue growth 3Y25.66%
Revenue growth 5Y-12.43%
Sales Q2Q%6.61%
Revenue Next Year13.29%
Revenue Next 2Y13.92%
Revenue Next 3Y13.37%
Revenue Next 5Y-1.25%
EBIT growth 1Y72.09%
EBIT growth 3Y24.41%
EBIT growth 5Y42.57%
EBIT Next Year56.93%
EBIT Next 3Y29.1%
EBIT Next 5YN/A
FCF growth 1Y231.56%
FCF growth 3YN/A
FCF growth 5Y59.47%
OCF growth 1Y165.01%
OCF growth 3Y272.45%
OCF growth 5Y47.49%